Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic perspectives in ischemic conditions].

Giuliano Rossi1

  • 1Primario Medico f.r., Ospedale San Filippo Neri, Roma.

Recenti Progressi in Medicina
|August 5, 2005
PubMed
Summary

Platelet-derived growth factor-CC (PDGF-CC) mobilizes endothelial progenitor cells and aids their differentiation, offering a new therapeutic avenue for ischemic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and classification of diabetes mellitus].

Recenti progressi in medicina·2010
Same author

[Diastolic dysfunction and diastolic heart failure].

Recenti progressi in medicina·2007
Same author

[Perspectives on neuroprotection. Could acid-sensing ion channels be a target of new treatments?].

Recenti progressi in medicina·2005
Same author

[Human metapneumovirus respiratory infections].

Recenti progressi in medicina·2005
Same author

["Quorum sensing" systems in infective pathology].

Recenti progressi in medicina·2005
Same author

[Chronic hepatitis C with normal level of alanine-aminotransferase].

Recenti progressi in medicina·2004

Area of Science:

  • Molecular biology
  • Cell biology
  • Vascular biology

Context:

  • Ischemic conditions impair tissue perfusion and oxygenation.
  • Endothelial progenitor cells (EPCs) play a crucial role in neovascularization.
  • Platelet-derived growth factor-CC (PDGF-CC) is a key regulator of cell growth and angiogenesis.

Purpose:

  • To elucidate the angiogenic mechanism of PDGF-CC.
  • To investigate the role of PDGF-CC in mobilizing EPCs.
  • To explore the potential of PDGF-CC in inducing endothelial differentiation.

Summary:

  • The study reveals that PDGF-CC possesses angiogenic properties by mobilizing EPCs in ischemic environments.
  • PDGF-CC was shown to induce the differentiation of bone marrow cells into functional endothelial cells.
  • This highlights PDGF-CC's significant role in promoting neovascularization.

Impact:

  • Modulating PDGF-CC activity presents a novel therapeutic strategy for treating ischemic diseases.
  • This research opens new avenues for regenerative medicine approaches in cardiovascular and peripheral vascular diseases.
  • Understanding PDGF-CC's mechanism could lead to targeted therapies for improving blood flow in ischemic tissues.

Related Experiment Videos